BAY 2416964 is primarily utilized in the field of oncology research as a potential therapeutic agent. It functions as an inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Researchers are investigating its efficacy in preclinical studies to determine its potential in treating various types of cancers, particularly those resistant to conventional therapies. The compound is also being explored for its role in combination therapies, where it may enhance the effectiveness of existing treatments. Additionally, its mechanism of action is being studied to better understand its impact on tumor growth and metastasis, with the aim of developing more targeted and effective cancer treatments.